#122: Top news in 2011--Apixaban win in ARISTOTLE; the heart can repair itself; dalcetrapib passes test in dal-VESSEL; FDA restricts simvastatin 80 mg; NIH stops AIM-HIGH; poor long-term outcomes post ablation of AF; caution with dabigatran in elderly; FD

Top news in 2011--Apixaban win in ARISTOTLE; the heart can repair itself; dalcetrapib passes test in dal-VESSEL; FDA restricts simvastatin 80 mg; NIH stops AIM-HIGH; poor long-term outcomes post ablation of AF; caution with dabigatran in elderly; FDA
Source: Radio TheHeart.org - Category: Cardiology Authors: Tags: This week in cardiology from heartwire Source Type: podcasts